World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
10178
World Ranking
3554
National Ranking
1643

Stanley J. Cryz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stanley J. Cryz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 186 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stanley J. Cryz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley J. Cryz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stanley J. Cryz is affiliated with the University of Massachusetts Chan Medical School in the United States. Their professional profile indicates active involvement in the academic and scientific community through work conducted at this institution.

There are no recent papers, frequent co-authors, or repetitive publication venues listed for Stanley J. Cryz. Additionally, no specific book publications or awards have been documented, which suggests either limited availability of publicly accessible records or a focus primarily on other forms of scholarly communication and research activities.

The absence of specified main fields of study, subfields, and main topics of work further indicates that detailed information regarding the scientific domains or research interests pursued by Stanley J. Cryz is not available at this time. This limits the ability to outline specific areas of expertise or thematic focus within their academic career.

Despite these gaps in detailed data, the affiliation with a recognized medical school suggests involvement in medical or biomedical sciences, a field that typically encompasses research, clinical studies, or education. The University of Massachusetts Chan Medical School is known for work in various medical sciences; however, without explicit data, it is not possible to identify precise subjects or contributions.

As the available data shows that Stanley J. Cryz is currently living, all information is presented in the present tense. The scientific profile, while limited in specifics, reflects the standard academic affiliation and potential for contributions typical of an active researcher at a university medical school.

Best Publications

  • Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.

    D E Ohman;S J Cryz;B H Iglewski

  • Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

    MyronM. Levine;Deirdre Herrington;Genevieve Losonsky;Ben Tall

  • Immunogenicity of new virosome influenza vaccine in elderly people.

    R Glück;R Mischler;B Finkel;J.U Que

  • Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

    D E Woods;S J Cryz;R L Friedman;B H Iglewski

  • Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

    Myron M. Levine;Catterine Ferreccio;Paulina Abrego;Oriana San Martin

  • Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.

    Emily Richie;Narain H Punjabi;Yuwono Sidharta;Kenny Peetosutan

  • Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

    M M Levine;C Ferreccio;S Cryz;E Ortiz

  • Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

    Carol O. Tacket;Mitchell B. Cohen;Steven S. Wasserman;Genevieve Losonsky

  • Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

    Deirdre A. Herrington;Lillian Van De Verg;Samuel B. Formal;Thomas L. Hale

  • Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR

    Carol O. Tacket;Genevieve Losonsky;James P. Nataro;Stanley J. Cryz

  • Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.

    Suharyono;C Simanjuntak;H Totosudirjo;N Witham

  • Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.

    S J Cryz;P M Mortimer;V Mansfield;R Germanier

  • Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand.

    Pisit Su-Arehawaratana;Preecha Singharaj;David N. Taylor;Charles Hoge;Charles Hoge

  • Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients.

    Pierre Conne;Laurent Gauthey;Philippe Vernet;Beat Althaus

  • Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant.

    Reinhard Glück;Robert Mischler;Peter Durrer;Emil Fürer

  • Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

    Michelle J Groome;Anthonet Koen;Alan Fix;Nicola Page;Nicola Page

  • Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

    Jean-Francois Viret;Didier Favre;Bernhard Wegmüller;Christian Herzog

  • Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.

    Carol O. Tacket;Genevieve Losonsky;James P. Nataro;Stanley J. Cryz

  • Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa Infections

    S T Donta;P Peduzzi;A S Cross;J Sadoff

  • Immunogenicity of a 24-Valent Klebsiella Capsular Polysaccharide Vaccine and an Eight-Valent Pseudomonas O-Polysaccharide Conjugate Vaccine Administered to Victims of Acute Trauma

    Wayne N. Campbell;Elizabeth Hendrix;Stanley Cryz;Alan S. Cross

  • Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

    U.B Schaad;J Wedgwood;A Ruedeberg;A.B Lang

Frequent Co-Authors

Myron M. Levine
Myron M. Levine University of Maryland, Baltimore
Jerald C. Sadoff
Jerald C. Sadoff Janssen (Belgium)
Genevieve Losonsky
Genevieve Losonsky University of Maryland, Baltimore
Alan S. Cross
Alan S. Cross University of Maryland, Baltimore
Steven S. Wasserman
Steven S. Wasserman University of Virginia
Carol O. Tacket
Carol O. Tacket University of Maryland, Baltimore
Barbara H. Iglewski
Barbara H. Iglewski University of Rochester
James B. Kaper
James B. Kaper University of Maryland, Baltimore
Robert R. Edelman
Robert R. Edelman Northwestern University
James P. Nataro
James P. Nataro University of Virginia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Immunology in the USA, exploring related healthcare degrees can broaden career opportunities. Many professionals consider advancing into specialized nursing roles with a focus on mental health or acute care, which complements immunology expertise.

One popular route is becoming a Psychiatric Mental Health Nurse Practitioner (PMHNP). Prospective students can find programs that offer great hands-on experiences by reviewing the best online pmhnp programs with high clinical placement rates. Affordability is also key; exploring the cheapest pmhnp programs can help manage educational costs while obtaining a quality education.

Graduates with advanced nursing degrees like the Doctor of Nursing Practice (DNP) often enjoy competitive salaries, which vary by region. To understand potential earnings, it’s helpful to consult information on how much do dnp nurses make, guiding financial planning and career decisions.

For those interested in acute care, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) is a common pathway. Detailed guidance can be found by exploring acnp programs, which outline the steps necessary to make this career move successfully.

Best Scientists Citing Stanley J. Cryz

Trending Scientists

Recently Published Articles